Author
|
DOP
|
Country
|
Period
|
Design
|
PE in ART
|
ART group
|
PE in NART
|
NART group
|
---|
Julie Hoy [42]
|
1999
|
Australia
|
1982–1995
|
Cohort
|
131
|
1552
|
399
|
7717
|
O.Salha [43]
|
1999
|
UK
|
1992–1997
|
Cohort
|
13
|
112
|
1
|
112
|
A.Geipel [44]
|
2001
|
Germany
|
1995–1999
|
Cohort
|
6
|
114
|
11
|
114
|
Anne Lynch [45]
|
2002
|
USA
|
1994–2000
|
Cohort
|
27
|
198
|
40
|
330
|
Syeda Zaib-un-Nisa [46]
|
2003
|
Emirates
|
1997–2001
|
Cohort
|
4
|
36
|
4
|
96
|
Pinborg [47]
|
2004
|
Denmark
|
1997
|
Cohort
|
71
|
870
|
49
|
566
|
Barbara Luke [48]
|
2004
|
USA
|
1990–2002
|
Cohort
|
25
|
228
|
24
|
725
|
Bengt Kallen [49]
|
2005
|
Sweden
|
1982–2001
|
Cohort
|
978
|
13,261
|
55,728
|
2,013,633
|
Fiona Thomson [50]
|
2005
|
Scotland
|
1989–1999
|
Cohort
|
70
|
1437
|
556
|
21,688
|
Sonia Hernandez-Diaz [51]
|
2006
|
USA & Canada
|
1998–2006
|
Cohort
|
18
|
349
|
115
|
4762
|
Erez [52]
|
2006
|
Israel
|
1988–2002
|
Cohort
|
51
|
292
|
193
|
2336
|
Prefumo [53]
|
2007
|
UK
|
NA
|
Case Control
|
1
|
31
|
1
|
62
|
Apantaku [24]
|
2008
|
UK
|
1999–2004
|
Cohort
|
6
|
88
|
7
|
88
|
Chen [54]
|
2009
|
Canada
|
2005
|
Cohort
|
34
|
1357
|
77
|
5190
|
Sun [55]
|
2009
|
Canada
|
2004–2007
|
Cohort
|
31
|
2118
|
112
|
8420
|
Morcel [56]
|
2010
|
France
|
2001–2005
|
Cohort
|
12
|
104
|
13
|
173
|
Miyake [57]
|
2010
|
Japan
|
2005–2007
|
Cohort
|
15
|
20
|
111
|
230
|
Suzuki [58]
|
2010
|
Japan
|
2000–2007
|
Cohort
|
4
|
64
|
9
|
87
|
Lehnen [28]
|
2011
|
Germany
|
2000–2009
|
Cohort
|
10
|
74
|
8
|
305
|
Yang [59]
|
2011
|
Korea
|
1995–2008
|
Cohort
|
9
|
67
|
22
|
143
|
Kuivasaari-Pirinen [60]
|
2012
|
Finland
|
1996–2007
|
Cohort
|
16
|
255
|
967
|
26,870
|
Bamberg [61]
|
2012
|
Germany
|
1998–2008
|
Cohort
|
14
|
426
|
24
|
813
|
Lubovnik [62]
|
2012
|
Slovenia
|
1997–2009
|
Case Control
|
55
|
246
|
126
|
477
|
Sazonova [63]
|
2012
|
Sweden
|
2002–2006
|
Cohort
|
520
|
11,292
|
15,984
|
571,914
|
Mohammed [64]
|
2012
|
Qatar
|
2002–2011
|
Cohort
|
27
|
145
|
30
|
175
|
Le Ray [65]
|
2012
|
France
|
2008–2010
|
Cohort
|
24
|
144
|
9
|
236
|
Emily Werder [66]
|
2013
|
USA
|
2002–2008
|
Cohort
|
45
|
215
|
62
|
232
|
Sara S. Malchau [67]
|
2013
|
Denmark
|
1995–2010
|
Cohort
|
1185
|
24,305
|
2519
|
56,022
|
Rocio Revello [68]
|
2013
|
Italy
|
2000–1010
|
Cohort
|
28
|
88
|
14
|
59
|
Sari Raisanen [69]
|
2013
|
Finland
|
2006–2010
|
Cohort
|
90
|
5647
|
3138
|
285,357
|
Alex Fong [70]
|
2014
|
USA
|
2009
|
Case Control
|
29
|
551
|
7487
|
406,334
|
Nathan S. Fox [71]
|
2014
|
USA
|
2005–2012
|
Case Control
|
61
|
376
|
15
|
137
|
Tandberg [39]
|
2014
|
Norway
|
1967–2009
|
Cohort
|
5516
|
8549
|
24,971
|
493,217
|
Tali Silberstein [72]
|
2014
|
Israel
|
NA
|
Cohort
|
113
|
1294
|
7889
|
171,513
|
Cagrı Arıoglu Aydın [23]
|
2015
|
Istanbul
|
2007–2010
|
Cohort
|
13
|
137
|
46
|
133
|
Anne-Maude Morency [73]
|
2015
|
Canada
|
2000–2013
|
Cohort
|
39
|
181
|
4
|
49
|
Robert Johnston [27]
|
2015
|
USA
|
2009
|
Cohort
|
29
|
551
|
7847
|
406,334
|
Malinda S. Lee [74]
|
2015
|
USA
|
2006–2008
|
Cohort
|
17
|
108
|
176
|
2284
|
Bay [75]
|
2016
|
Denmark
|
1999–2013
|
Cohort
|
2675
|
30,418
|
37,531
|
896,448
|
DoPierala [76]
|
2016
|
UK
|
1992–2009
|
Cohort
|
203
|
3188
|
2341
|
52,443
|
Nejdet [77]
|
2016
|
Sweden
|
2003–2012
|
Cohort
|
1156
|
27,084
|
27,912
|
999,804
|
Zhu [78]
|
2016
|
China
|
2006–2014
|
Cohort
|
98
|
2641
|
110
|
5282
|
Vikstrom [79]
|
2016
|
Sweden
|
1988–2012
|
Case Control
|
607
|
10,412
|
822
|
18,624
|
Ben-Yaakov [80]
|
2016
|
Israel
|
1988–2012
|
Cohort
|
378
|
4153
|
4471
|
95,138
|
Sun [81]
|
2016
|
China
|
2010–2014
|
Cohort
|
42
|
411
|
54
|
742
|
Valenzuela-Alcaraz [26]
|
2016
|
Spain
|
2004–2010
|
Cohort
|
6
|
488
|
0
|
200
|
Rizzo [82]
|
2016
|
Italy
|
2007–2014
|
Cohort
|
17
|
249
|
6
|
260
|
Guilbaud [25]
|
2017
|
France
|
2010–2014
|
Cohort
|
41
|
303
|
32
|
369
|
- DOP Date of publication, PE Preeclampsia, ART Assisted Reproductive Technology, NART Non-Assisted Reproductive Technology